MediLumine

MediLumine is a specialized biotechnology company focused on providing advanced imaging reagents and instrumentation for preclinical research applications. The company offers an extensive portfolio of contrast agents tailored for micro-CT, MRI, ultrasound, and optical imaging, including well-known brands such as Fenestra and ExiTron. Beyond reagents, MediLumine develops the Prism series of optical imaging systems, which enable high-sensitivity fluorescence and bioluminescence detection in small animal models. Their products are designed to enhance the visualization of physiological processes and disease progression, supporting researchers in fields like oncology and cardiology. By providing high-quality molecular probes and hardware, MediLumine facilitates longitudinal in vivo studies and drug discovery efforts. The company is headquartered in Montreal and serves a global customer base in academia and the pharmaceutical industry.